Glycobiology Market, By Product Type (Instruments, Enzymes (Galactosidases (Fucosidases, Chitinases, Acetylgalactosaminidase, Heparinase, PNGase F, and Others), GlcNAc Transferases (Acetylglucosaminyltransferase, Exostosin, and Others), Fucosyltransferase

Glycobiology Market, By Product Type (Instruments, Enzymes (Galactosidases (Fucosidases, Chitinases, Acetylgalactosaminidase, Heparinase, PNGase F, and Others), GlcNAc Transferases (Acetylglucosaminyltransferase, Exostosin, and Others), Fucosyltransferases, GalNAc Transferases, Galactosyl Transferases, Glucuronosyltransferases, Glucosyltransferases, Pentosyltransferases, Carbohydrate Kinases, Neuraminidases, Sialyltransferases, and Others), Consumables, Reagents & Kits), By Application (Drug Discovery and Development, Diagnostic Applications (Oncology, Immunology, and Others), Industrial Application, Therapeutic Application (Oncology, Immunology, and Others), and Others), By End User, (Pharmaceutical Companies, Research Laboratories, Hospitals, Diagnostic Centers, Contract Research Organizations, Biotechnology Companies, Academic Institutes, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Glycobiology is the study of entire biology that includes structure and function of molecules containing carbohydrates (sugar and saccharides) also called as glycans. It is very helpful in biotechnological research and biomedicine. Carbohydrates control almost all the aspects of cellular processing that involves cell-cell interactions, adhesion mechanisms, signalling for growth factors, blood clotting, regulating hormonal activity, and it also directs embryonic development. Study of glycobiology has variety of application in areas such as drug discovery and development, diagnostic applications, therapeutic applications, and industrial applications. Glycobiology research include glycoengineering of carbohydrate, sugars, monosaccharides, oligosaccharides, or polysaccharides. Glycoengineering is a method of improving the properties of proteins by changing their glycosylation. Glycoengineered proteins are widely used in medicine industry, agriculture, environmental protection, and other fields.
Market Dynamics
Key players operating in the global glycobiology market are focusing on adoption of inorganic growth strategies such as acquisition, which is expected to drive the market growth during the forecast period. For instance, in April 2018, Bruker Corporation acquired Anasys Instruments Corp. (Anasys), a privately held company, for a purchase price of US$ 27.0 million. After the acquisition, Anasys strengthened the product portfolio of Bruker Corporation by adding various products such as nanoscale infrared spectroscopy and thermal measurement instruments. Furthermore, in July 2018, Bruker Corporation acquired JPK Instruments AG (JPK), a privately held company, to enhance their in-depth expertise in live-cell imaging, cellular mechanics, adhesion and molecular force measurements, optical trapping, biological stimulus etc. to Bruker Corporation.
Key features of the study:
This report provides in-depth analysis of the global glycobiology market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global glycobiology market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Merck & Co., Inc., Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Plexera LLC, New England Biolabs, and Agilent Technologies, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycobiology market.
Detailed Segmentation:
Global Glycobiology Market, By Product Type:
Instruments
Enzymes
Galactosidases
Fucosidases
Chitinases
Acetylgalactosaminidase
Heparinase
PNGase F
Others
GlcNAc Transferases
Acetylglucosaminyltransferase
Exostosin
Others
Fucosyltransferases
GalNAc Transferases
Galactosyl Transferases
Glucuronosyltransferases
Glucosyltransferases
Pentosyltransferases
Carbohydrate Kinases
Neuraminidases
Sialyltransferases
Others
Consumables
Reagents & Kits
Global Glycobiology Market, By Application:
Drug Discovery and Development
Diagnostic Applications
Oncology
Immunology
Others
Industrial Application
Therapeutic Application
Oncology
Immunology
Others
Others
Global Glycobiology Market, By End User:
Pharmaceutical Companies
Research Laboratories
Hospitals
Diagnostic Centers
Contract Research Organizations
Biotechnology Companies
Academic Institutes
Others
Global Glycobiology Market, By Region:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profiles
Merck & Co., Inc*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Bio-Techne Corporation
Bruker Corporation
Thermo Fisher Scientific Inc.
Shimadzu Corporation
Plexera LLC
New England Biolabs
Agilent Technologies, Inc.
“*” marked represents similar segmentation in other categories in the respective section.